73207-0304 ROMVIMZA - CanMED: NDC

Product NDC:

73207-0304

Brand Name:

ROMVIMZA

Generic Name:

Vimseltinib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: VIMSELTINIB

Strength: 30.0

Unit: mg/1

Packages:

Code: 73207-0304-40

Description: 1 CARTON in 1 CARTON (73207-304-40) / 1 BLISTER PACK in 1 CARTON / 8 CAPSULE in 1 BLISTER PACK

Effective Date: Feb. 14, 2025

Discontinued:

Code: 73207-0304-41

Description: 1 CARTON in 1 CARTON (73207-304-41) / 1 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK

Effective Date: Feb. 14, 2025

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

CSF1R

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox